Telmisartan: Clinical Trials

69 trials of Telmisartan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

50 completed, 10 unknown, 4 terminated, 1 active not recruiting. 69 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 469Completed 50, Unknown 10, Terminated 4, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1, Suspended 1, Withdrawn 1

Follow Telmisartan: new trials by email Literature Review of Telmisartan trials Research Report on Telmisartan

Trials (filtered) newest first · largest first

All 69 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Mineralocorticoid Receptor Antagonist Therapy for Low-Renin Essential Hypertension
Eplerenone, Telmisartan - Hypertension (HTN), Low-Renin Essential Hypertension
Phase 4Not yet recruitingChina National Center for Cardiovascular Diseases1282026-12-012026-11-20
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
Finerenone, Semaglutide, Lotensin - Chronic Kidney Disease, Type 2 Diabetes
Phase 4Enrolling by invitationBaylor Research Institute642026-04-082026-10-13
Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg, Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg - Essential Hypertension
Phase 4Active not recruitingYuhan Corporation1982023-10-182026-02-13
A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
Telmisartan, Losartan - Essential Hypertension, Metabolic Syndrome
Phase 4UnknownChong Kun Dang Pharmaceutical1162023-06-012023-05-06
Efficacy and Safety of Telmisartan Compared With Losartan
telmisartan, Losartan - Diabetic Nephropathies, Hypertension
Phase 4UnknownChong Kun Dang Pharmaceutical982023-04-192024-05-28
Occurrence of Dyskalemia With Treatment for Hypertension
Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg - Hypertension, Potassium Imbalance
Phase 4CompletedNational Heart Foundation of Bangladesh10902022-01-152023-07-14
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease
Angiotensin Receptor Blockers, Placebo - Coronavirus Disease 2019, COVID-19
Phase 4CompletedThe George Institute7872020-06-192022-03-17
Coronavirus (COVID-19) ACEi/ARB Investigation
Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor - Hypertension, COVID-19
Phase 4SuspendedNational University of Ireland, Galway, Ireland24142020-04-302020-06-30
HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
Telmisartan/Rosuvastatin 40/10mg, Telmisartan 40mg - Chronic Kidney Disease, Proteinuria
Phase 4UnknownYuhan Corporation3742018-06-052020-12-14
Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)
Linagliptin, Empagliflozin, Telmisartan - Diabetic Nephropathy Type 2
Phase 4WithdrawnSteno Diabetes Center Copenhagen2017-11-152018-09-14
Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension
Duowell®, Telmisartan - Hypertension, Dyslipidemia
Phase 4CompletedYuhan Corporation802017-09-112021-04-06
A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome
Telmisartan 40mg + Rosuvastatin 20mg, Telmisartan 80mg + Rosuvastatin 20mg, Telmisartan 40mg, 80 mg - Metabolic Syndrome
Phase 4TerminatedYuhan Corporation552016-10-012019-04-12
S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension
S-amlodipine 2.5mg + Chlorthalidone 25mg, S-amlodipine 2.5mg + Telmisartan 40mg - Essential Hypertension
Phase 4UnknownSeoul National University Bundang Hospital1702015-12-022017-07-21
Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation
Telmisartan 80 mg and amlodipine 5 mg, Placebo (for telmisartan and amlodipine) - Atrial Fibrillation
Phase 4CompletedResearch Institute for Complex Problems of Cardiovascular Diseases, Russia642015-11-012017-03-22
INTERVENCION Trial
Hydrochlorothiazide, Amlodipine, Telmisartan - Blood Pressure, High
Phase 4CompletedPrevencion1662014-09-012025-07-29
Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease
Perindopril, Telmisartan, Amlodipine - Nonalcoholic Fatty Liver Disease (NAFLD)
Phase 4UnknownNanfang Hospital, Southern Medical University1802014-08-012014-08-11
The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy
Telminuvo®Tab. 40/2.5mg, Telmitrend®Tab. 80mg - Hypertension
Phase 4CompletedChong Kun Dang Pharmaceutical2172014-06-012020-01-31
A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R
Azilsartan, Telmisartan - Essential Hypertension Complicated by Type 2 Diabetes Mellitus
Phase 4CompletedTakeda332014-06-012017-08-02
Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms
Telmisartan, Placebo - Abdominal Aortic Aneurysm
Phase 4CompletedPalo Alto Veterans Institute for Research222012-09-192020-05-26
HIGH Altitude CArdiovascular REsearch in the ANDES
Telmisartan, Nifedipine, placebo - Hypertension, High Altitude
Phase 4CompletedIstituto Auxologico Italiano1002012-05-012013-04-12

Showing 20 of 69. Sign in to see all of them.

Conditions studied

Hypertension (45)  ·  Essential Hypertension (6)  ·  Renal Insufficiency, Chronic (5)  ·  Cardiovascular Diseases (4)  ·  Coronary Artery Disease (4)  ·  Diabetes Mellitus, Type 2 (4)  ·  Diabetic Nephropathies (4)  ·  Metabolic Syndrome (4)  ·  Stroke (3)  ·  Atrial Fibrillation (2)  ·  COVID-19 (2)  ·  Hyperkalemia (2)  ·  Proteinuria (2)  ·  Acute Coronary Syndrome (1)  ·  Albuminuria (1)

Sponsors

Boehringer Ingelheim (26)  ·  Yuhan Corporation (4)  ·  Chong Kun Dang Pharmaceutical (3)  ·  University of Vigo (2)  ·  Aligarh Muslim University (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Bayer (1)  ·  Baylor Research Institute (1)  ·  Biomedis International Ltd. (1)  ·  Catholic University of the Sacred Heart (1)  ·  China National Center for Cardiovascular Diseases (1)  ·  Chinese Academy of Medical Sciences, Fuwai Hospital (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Heart Care Foundation (1)  ·  Istituto Auxologico Italiano (1)

Countries

South Korea (15)  ·  Germany (11)  ·  United States (11)  ·  Spain (10)  ·  China (8)  ·  France (8)  ·  Italy (8)  ·  Canada (6)  ·  Japan (6)  ·  Denmark (5)  ·  Mexico (5)  ·  Australia (4)  ·  Austria (4)  ·  Brazil (4)  ·  Ireland (4)

Top investigators

Ramon C Hermida, PhD (2)  ·  Alfonso M. M Cueto-Manzano, MD, MSc, PhD (1)  ·  BeomSeok Kim, M.D, Ph.D (1)  ·  Do-Sun Lim, MD, PhD (1)  ·  Fazilatunnesa Malik, MBBS, FCPS (1)  ·  Gennaro Cice, MD (1)  ·  Gianfranco Parati, MD, PhD (1)  ·  Hirofumi Soejima, MD, PhD (1)  ·  Hisao Ogawa, Prof., MD, PhD (1)  ·  Hyo-Soo Kim, Professor (1)

Results publications

PMID 38682786, PMID 32905623, PMID 36398903, PMID 17339550, PMID 18378520, PMID 18496508, PMID 18537808, PMID 18707986, PMID 18753638, PMID 18753639, PMID 18757085, PMID 18757238, PMID 19407805, PMID 19451556, PMID 19463506, PMID 19506526, PMID 19683638, PMID 19770395, PMID 20231536, PMID 20980201, PMID 21070920, PMID 21200437, PMID 21252701, PMID 21263104, PMID 21357827, PMID 21617110, PMID 21700754, PMID 21788624, PMID 21884956, PMID 21947289, PMID 22089721, PMID 22192672, PMID 22267825, PMID 22329591, PMID 22495138, PMID 22525206, PMID 22552566, PMID 22717420, PMID 22738922, PMID 22829023, PMID 22922507, PMID 23184565, PMID 23212996, PMID 23282123, PMID 23630950, PMID 23895814, PMID 23939297, PMID 23988639, PMID 24191305, PMID 24356937

NIH funding

2008 (1), 2009 (1)